However, ZEB2 expression was higher in acute myeloid leukemia (LAML), brain lower grade glioma (LGG), pancreatic adenocarcinoma (PAAD), and skin cutaneous melanoma (SKCM) than in normal tissue (Figure 1). Here, ZEB2 is linked to acute myeloid leukemia.